GeneDx (WGS) Earnings Date, Estimates & Call Transcripts

$33.53

+0.81 (+2.48%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Jul. 30
After Market Closes
Confirmed
Actual EPS (Apr. 29): -$0.33 Beat By $0.35
Consensus EPS (Apr. 29): -$0.68

WGS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WGS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

GeneDx Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	1	($0.03)	($0.03)	($0.03)
Q2 2024	1	($0.04)	($0.04)	($0.04)
Q3 2024	1	($0.04)	($0.04)	($0.04)
Q4 2024	1	($0.04)	($0.04)	($0.04)
FY 2024	4	($0.15)	($0.15)		($0.15)

WGS Earnings Date and Information

GeneDx last issued its earnings results on April 29th, 2024. The reported ($0.33) earnings per share for the quarter, topping analysts' consensus estimates of ($0.68) by $0.35. The firm earned $62.42 million during the quarter, compared to analyst estimates of $49.80 million. GeneDx has generated ($5.18) earnings per share over the last year (($5.18) diluted earnings per share). Earnings for GeneDx are expected to grow in the coming year, from ($0.92) to $0.05 per share. GeneDx has confirmed that its next quarterly earnings report will be published on Tuesday, July 30th, 2024. GeneDx will be holding an earnings conference call on Tuesday, July 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

GeneDx Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
7/30/2024 (Confirmed)	-	-	-	-	-	-	-
4/29/2024	Q1 2024	($0.68)	($0.33)	+$0.35	$0.12	$49.80 million	$62.42 million
2/20/2024	Q4 2023	($0.60)	($0.59)	+$0.01	($0.26)	$57.00 million	$57.42 million
10/30/2023	Q3 2023	($1.18)	($0.82)	+$0.36	-	$53.80 million	$53.30 million
8/8/2023	Q2 2023	($1.47)	($1.65)	($0.18)	($1.46)	$45.60 million	$48.71 million
5/9/2023	Q1 2023	($1.65)	($2.82)	($1.17)	($2.60)	$37.90 million	$43.14 million
11/14/2022	Q3 2022	($6.27)	($6.60)	($0.33)	($0.20)	$76.60 million	$83.23 million
Get the Latest News and Ratings for WGS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter.
11/14/2022	Q3 2022	($6.27)	($6.60)	($0.33)	($0.20)	$76.60 million	$83.23 million
8/15/2022	Q2 2022	($6.27)	($6.93)	($0.66)	($0.17)	$71.90 million	$36.17 million
8/15/2022	Q2 2022	($6.27)	($6.93)	($0.66)	($0.17)	$71.90 million	$36.17 million
5/12/2022	Q1 2022	($9.24)	($8.58)	+$0.66	($0.21)	$48.00 million	$53.94 million
5/12/2022	Q1 2022	($9.24)	($8.58)	+$0.66	($0.21)	$48.00 million	$53.94 million
3/14/2022	Q4 2021	($7.26)	($5.61)	+$1.65	($0.17)	$50.90 million	$57.80 million
3/14/2022	Q4 2021	($7.26)	($5.61)	+$1.65	($0.17)	$50.90 million	$57.80 million
11/15/2021	Q3 2021	($6.27)	$4.95	+$11.22	($1.01)	$42.00 million	$43.18 million
11/15/2021	Q3 2021	($5.28)	($14.19)	($8.91)	($1.01)	$42.00 million	$43.18 million

GeneDx Earnings - Frequently Asked Questions

When is GeneDx's earnings date?: GeneDx has confirmed that its next quarterly earnings data will be published on Tuesday, July 30th, 2024. Learn more on WGS's earnings history.
What guidance has GeneDx issued on next quarter's earnings?: GeneDx issued an update on its FY 2024 earnings guidance on Monday, April, 29th. The company issued revenue guidance of $235.0 million-$245.0 million, compared to the consensus revenue estimate of $226.1 million.
Did GeneDx beat their earnings estimates last quarter?: In the previous quarter, GeneDx (NASDAQ:WGS) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.35. Learn more on analysts' earnings estimate vs. WGS's actual earnings.
How much revenue does GeneDx generate each year?: GeneDx (NASDAQ:WGS) has a recorded annual revenue of $202.57 million.
How much profit does GeneDx generate each year?: GeneDx (NASDAQ:WGS) has a recorded net income of -$175.77 million. WGS has generated -$5.18 earnings per share over the last four quarters.
What is GeneDx's EPS forecast for next year?: GeneDx's earnings are expected to grow from ($0.92) per share to $0.05 per share in the next year.